Medicinal herb,Thonningia sanguinea protects against aflatoxin B1 acute hepatotoxicity in Fischer 344 rats

Abstract

1. Thonningia sanguinea, a plant used prophylactically against bronchial asthma in Ghana was recently found to have antioxidative and hepatoprotective actions in our laboratory.

2. In this study, the effect of T. sanguinea extract on certain biochemical indices in serum and liver of Fischer 344 rats given a single intraperitoneal (i.p.) dose (1 mg/kg) of aflatoxin B1 (AFB1) was investigated.

3. Administration of AFB1 resulted in significant increases in serum alanine aminotransferase (ALT) and glutathione S-transferase (GST) levels and a signifi-cant decrease in aniline hydroxylase activity in liver microsomes. When T. sanguinea (5 ml/kg) was intraperitoneally administered to rats 12 h and 1 h before AFB1, liver injury was significantly reduced as seen in the decreased levels of serum ALT and serum GST. However, the decrease in aniline hydroxylase activity by AFB1 was not recovered but enhanced by T. sanguinea pre-treatment.

4. Kinetic analysis of cytochrome P450 activity of rat liver microsomes in vitro demonstrated that T. sanguinea inhibited aniline hydroxylase non-competitively suggesting depression of biotransformation of AFB1 to toxic metabolites.

5. The data indicate a hepatoprotective action of T. sanguinea against AFB1-induced liver injury.

Keywords

T. sanguinea aflatoxin B1 antioxidant cytochrome P450 hepatotoxicity inhibition monooxygenases

Get full access to this article

View all access options for this article.

References

Nyarko AK , Addy ME. In vitro screening for the anti-anaphylatic agent in Thonningia sanguinea . J. Ethnopharmacol 1994; 41: 45-51 .

Groopman JD. Molecular dosimetry for assessing human aflatoxin exposure. In Eaton DL , Groopman JD (eds). The Toxicology of Aflatoxins: Human Health, Veternary and Agricultural Significance. Academic: New York . 259-280. 1994.

Hendrickse RG. The influence of aflatoxins on child health in the tropics with particular reference to kwashiokor . Trans Royal Soc Trop Med Hygiene 1984; 78: 427-435 .

Groopman JD , Cain LD , Kensler T. Aflatoxin exposure in human populations: measurements and relationship to cancer . CRC Crit Rev Toxicol 1988; 19: 113-143 .

Hall AJ , Wild CP Epidemiology of Aflatoxin-related disease. In Eaton DL , Groopman JD (eds). The Toxicology of Aflatoxins: Human Health, Veternary and Agricultural Significance. Academic: New York . 233-258, 1994.

Massey TE et al. Biochemical and molecular aspects of mammalian susceptibility to aflatoxin B1 carcinogenicity . Proc Soc Exp Biol Med 1995; 208: 213-227 .

Diallo MS et al. Prevalence of exposure to aflatoxin and hepatitis B and C viruses in Guinea, West Africa . Nat Toxins 1995: 3: 6-9 .

Garner RC , Martin CN. Fungal toxins, aflatoxins and nucleic acids. In: Grover PL (ed). Chemical Carcinogens and DNA Vol I. CRC Press, Boca-Raton , 187-225. 1979.

Essigman JM , Croy RG , Bennet RA , Wogen GN. Metabolic activation of aflatoxin B1: patterns of DNA adduct formation, removal and excretion in relation to carcinogenesis . Drug Metabol Rev 1982; 13: 581-602 .

10.

Mclellan IL , Judah DJ , Neal GE , Hayes D. Regulation of aflatoxin B1-metabolizing aldehyde reductase and glutathione S-transferase by chemoprotectors . Biochem J. 1994; 300: 117-124 .

11.

Hashim S et al. Modulating effect of essential oils from spices on the formation of DNA adduct by aflatoxin B1 in vitro . Nutr Cancer 1994; 21: 169-175 .

12.

Goswami UC , Saloi TN , Firozi PF , Bhattacharya RK. Modulation by some natural carotenoids of DNA adduct formation by aflatoxin B1 in vitro . Cancer Lett 1989; 47: 127-132 .

13.

Wattenberg LW , Speier J , Kotake A. Effects of antioxidants on metabolism of aromatic polycyclic hydrocarbons . Adv Enzyme Regul 1976; 14: 313-322 .

14.

Ip SP et al. Effect of a lignin-enriched extract of Schisandra chinensis on aflatoxin B1 and cadmium chloride-induced hepatotoxicity in rats . Pharmacol Toxicol 1996 78: 413-416 .

15.

Lin JK , Wang CJ. Protection of crocin dyes on the acute hepatic damage induced by aflatoxin B1 and dimethylnitrosamine . Carcinogenes 1986; 7: 595-599 .

16.

Langouët S et al. Inhibition of CYP1A2 and CYP3A4 by Oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary culture . Cancer Res 1995; 55: 5574-5579 .

17.

Shen HM , Shi CY , Lee HP , Ong CN. Aflatoxin B1- induced lipid peroxidation in rat liver . Toxicol Appl Pharmacol 1994; 127: 145-150 .

18.

Shen HM , Ong CN , Shi CY. Involvement of reactive oxygen species in aflatoxin B1-induced cell injury in cultured rats hepatocytes . Toxicology 1995; 99: 115-123 .

19.

Habig WH , Pabst MJ , Jakoby WB. Glutathione S-transferase . JBiolChem 1974; 249: 7130-7139 .

20.

Imai Y , Ito A , Sato R. Evidence for biochemically different types of vescile in the hepatic microsomal fraction . J Biochem (Tokyo) 1966; 60: 417-428 .

21.

Reed DJ et al. High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide and related thiols and disulfides . Ana Biochem. 1980; 106: 55-62 .

22.

Naito A , Aniya Y , Sakanashi M. Antioxidative action of the nitrovasodilator nicorandil: Inhibition of oxidative action of liver microsomal S-transferase and lipid peroxidation . Jpn J Pharmacol 1994; 65: 209-213 .

23.

Lowry OH , Rosebrough NJ , Farr AL , Randall RJ. Protein measurement with Folin phenol reagent . J Biol Chem 1951; 193: 265-275 .

24.

Choy WN. A review of the dose-response induction of DNA adducts by aflatoxin B1 and its implications to quantitative cancer-risk assessment . Mutat Res 1993; 296: 181-198 .

25.

Prochaska HJ , De Long MJ , Talalay P. On the mechanism of induction of cancer protective enzymes: A unifying proposal . Proc Natl Acad Sci USA 1985; 82: 8232-8236 .

26.

Yoshizawa H et al. Metabolism and activation of aflatoxin B1 by reconstituted cytochrome P450 system of rat liver . Cancer Res 1982; 42: 1120-1124 .

27.

Robertson IG , Zeiger E , Goldstein JA. Specificity of rat liver cytochrome P-450 isozymes in the mutagenic activation of benzo[a]pyrene, aromatic amines and aflatoxin B1 . Carcinogenesis 1983; 4: 93-96 .

28.

Forrester LM et al. Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver . Proc Natl Acad Sci USA 1990; 87: 8306-8310 .

29.

Crespi CL et al. The development of human cell line stably expressing human CYP3A4: Role in the metabolic activation of aflatoxin B1 and comparison to CYP1A2 and CYP2A3 . Carcinogenesis 1991; 12, 355-359 .

30.

Soucek P , Gut I. Cytochrome P-450 in rats: Structures, functions, properties and relevant human forms . Xenobiotica 1992; 22: 83-103 .

31.

Guengerich FP. Roles of cytochrome P-450 enzymes in chemical carcinogesis and cancer chemotherapy . Cancer Res 1988; 48: 2946-2954 .

32.

Shimada T , Okuda Y. Metabolic activation of environmental carcinogens and mutagens by human liver microsomes . Biochem Pharmacol 1988; 37: 459-465 .